Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Keogh

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
EDTNA/ERCA Journal (English Ed.)|October 10, 2002
The use of clinical reasoning to promote patient choiceAnne M Keogh, Jan Macefield
Therapeutic Drug Monitoring|October 14, 2006
Apparent clearance of sirolimus in heart transplant recipients: impact of primary diagnosis and serum lipidsHamim Zahir, Anne M Keogh, Fatemeh Akhlaghi
European Heart Journal|September 14, 2022
Pulmonary haemodynamics and pulmonary congestion: where are we now?Nicole K Bart, Eugene Kotlyar, Anne M Keogh
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 19, 2006
Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoringJohn E Ray, Anne M Keogh, Andrew J McLachlan
Heart, Lung & Circulation|August 26, 2022
Portopulmonary Hypertension: The Interplay Between the Liver and Pulmonary ArteriesNicole K Bart, Ken Liu, Eugene Kotlyar, et al.
Journal of the American College of Cardiology|December 10, 2013
Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertensionPaul Bhamra-Ariza, Anne M Keogh, David W M Muller
Vascular Health and Risk Management|February 3, 2009
Clinical deterioration after sildenafil cessation in patients with pulmonary hypertensionAnne M Keogh, Andrew Jabbour, Christopher S Hayward, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 23, 2003
Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitorsJohn E Ray, Anne M Keogh, Andrew J McLachlan, et al.
Transplantation|June 28, 2003
Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriolN Kathryn Briffa, Anne M Keogh, Philip N Sambrook, et al.
The Medical Journal of Australia|May 27, 2003
Pulmonary arterial hypertension: a new era in managementAnne M Keogh, Keith D McNeil, Trevor Williams, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
EDTNA/ERCA Journal (English Ed.)|October 10, 2002
The use of clinical reasoning to promote patient choiceAnne M Keogh, Jan Macefield
Therapeutic Drug Monitoring|October 14, 2006
Apparent clearance of sirolimus in heart transplant recipients: impact of primary diagnosis and serum lipidsHamim Zahir, Anne M Keogh, Fatemeh Akhlaghi
European Heart Journal|September 14, 2022
Pulmonary haemodynamics and pulmonary congestion: where are we now?Nicole K Bart, Eugene Kotlyar, Anne M Keogh
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 19, 2006
Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoringJohn E Ray, Anne M Keogh, Andrew J McLachlan
Heart, Lung & Circulation|August 26, 2022
Portopulmonary Hypertension: The Interplay Between the Liver and Pulmonary ArteriesNicole K Bart, Ken Liu, Eugene Kotlyar, et al.
Journal of the American College of Cardiology|December 10, 2013
Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertensionPaul Bhamra-Ariza, Anne M Keogh, David W M Muller
Vascular Health and Risk Management|February 3, 2009
Clinical deterioration after sildenafil cessation in patients with pulmonary hypertensionAnne M Keogh, Andrew Jabbour, Christopher S Hayward, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 23, 2003
Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitorsJohn E Ray, Anne M Keogh, Andrew J McLachlan, et al.
Transplantation|June 28, 2003
Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriolN Kathryn Briffa, Anne M Keogh, Philip N Sambrook, et al.
The Medical Journal of Australia|May 27, 2003
Pulmonary arterial hypertension: a new era in managementAnne M Keogh, Keith D McNeil, Trevor Williams, et al.
Pageof 7